Stock listing

Lang & Schwarz:A41HBE Qiagen N.V. Aktie

German listing (Lang & Schwarz) of Qiagen N.V. · home listing NYSE:QGEN

Follow Qiagen N.V. into a list and get an email when it puts out news.

Home listing price · NYSE:QGEN

$46.13 USD -0.04 (-0.1%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:QGEN

Since Jul 6, 2026 +17.8% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$45.97 – $46.74 USDOct 16, 2026
Volume
2.00M sharesOct 16, 2026
Market value
$9.53B USDAt the close on Oct 16, 2026 · price × 206.5M shares outstanding
Qiagen N.V. logo
Ticker
Lang & Schwarz:A41HBE
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Calls

Replays

  • Qiagen (NYSE:QGEN) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 9:30 AM ET

    Watch Transcript

  • Qiagen (NYSE:QGEN) Q1 2026 Earnings Call

    Tue, Apr 28, 2026 · 9:30 AM ET

    Watch Transcript

  • Qiagen (NYSE:QGEN) Q4 2025 Earnings Call

    Thu, Feb 05, 2026 · 9:30 AM ET

    Watch Transcript

Latest news

QIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against Tuberculosis

Oct 13, 2026

QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery

Oct 6, 2026

QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel

Sep 28, 2026

QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation

Sep 24, 2026

QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board

Sep 18, 2026

QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction

Aug 27, 2026

QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer

Aug 24, 2026

2026 Annual Report 2026 IFRS Half Year Report

Aug 20, 2026

QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel

Aug 10, 2026

QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook

Aug 5, 2026

All Qiagen N.V. news

Decks

Qiagen N.V. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
44 in the last 12 months · 71 in all · newest Oct 13, 2026 · oldest 2025
Calls
22 calls with a replay · 22 with a transcript · latest Aug 6, 2026
Decks
130 decks · latest September 2026

Where Qiagen N.V. is listed

ListingExchangeCountryCurrency
NYSE:QGEN · Home listingNYSEUnited StatesUSD
Xetra:QIAXetraGermanyEUR
gettex:QIAgettexGermanyEUR
Tradegate:QIATradegateGermanyEUR
LS Exchange:A41HBELS ExchangeGermanyEUR
Stuttgart:QIAStuttgartGermanyEUR
EUROTLX:4QGENEUROTLXItalyEUR
Milan:1QGENMilanItalyEUR
Frankfurt:QIAFrankfurtGermanyEUR
Lang & Schwarz:A41HBE · This pageLang & SchwarzGermanyEUR
LSIN:0RLTLSINUnited KingdomEUR
LS Exchange:A400D5LS ExchangeGermanyEUR
BX Swiss:QGENBX SwissSwitzerlandCHF
Dusseldorf:QIADusseldorfGermanyEUR
BOATS:QGENBOATSUnited StatesUSD
BX Swiss:QGENEURBX SwissSwitzerlandEUR
Hanover:QIAHanoverGermanyEUR
Munich:QIAMunichGermanyEUR
Hamburg:QIAHamburgGermanyEUR
VIE:QGE4ViennaAustriaEUR
Aquis:QIADAquisUnited KingdomEUR
Aquis:QIADAquisUnited KingdomEUR
Lang & Schwarz:A400D5Lang & SchwarzGermanyEUR
BIVA:QIANBIVAMexicoMXN
BMV:QIANBMVMexicoMXN
Turquoise:QIADTurquoiseUnited KingdomEUR

Log in to ask 6ix AI your own questions about Qiagen N.V.